Reviva Pharmaceuticals Holdings (Reviva Pharmaceuticals Holdings) Total Equity : $-1.35 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Reviva Pharmaceuticals Holdings Total Equity?

Reviva Pharmaceuticals Holdings's total equity for the quarter that ended in Mar. 2024 was $-1.35 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Reviva Pharmaceuticals Holdings Total Equity Historical Data

The historical data trend for Reviva Pharmaceuticals Holdings's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Reviva Pharmaceuticals Holdings Total Equity Chart

Reviva Pharmaceuticals Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Total Equity

-6.81

5.47

28.69

8.39

5.72

Reviva Pharmaceuticals Holdings Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Equity	Get a 7-Day Free Trial													5.79	1.62	-8.52	5.72	-1.35

Reviva Pharmaceuticals Holdings Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Reviva Pharmaceuticals Holdings's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2023 )	-	Total Liabilities(Q: Dec. 2023 )
	=	23.7	-	17.982
	=	5.72

Reviva Pharmaceuticals Holdings's Total Equity for the quarter that ended in Mar. 2024 is calculated as

Total Equity	=	Total Assets(Q: Mar. 2024 )	-	Total Liabilities(Q: Mar. 2024 )
	=	13.497	-	14.842
	=	-1.35

Reviva Pharmaceuticals Holdings Total Equity Related Terms

Thank you for viewing the detailed overview of Reviva Pharmaceuticals Holdings's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Reviva Pharmaceuticals Holdings (Reviva Pharmaceuticals Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Reviva Pharmaceuticals Holdings Inc (NAS:RVPHW) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

RVPH:USA

Address

19925 Stevens Creek Boulevard, Suite 100, Cupertino, CA, USA, 95014

Website

https://www.revivapharma.com

Reviva Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, respiratory, and metabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, 1) Brilaroxazine (RP5063) which is in clinical development and is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and 2) RP1208.